Saving changes...

Done

Error

Using SCIT vs. SLIT to Modify Allergic Disease

Using SCIT vs. SLIT to Modify Allergic Disease

Using SCIT vs. SLIT to Modify Allergic Disease

Stephen R. Durham (MA MD FRCP), Mohamed H. Shamji (PhD FAAAAI), and Giovanni Passalacqua (MD)
Stephen R. Durham (MA MD FRCP), Mohamed H. Shamji (PhD FAAAAI), and Giovanni Passalacqua (MD)
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 02 Jul 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190508

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course offers an in-depth explanation of using SCIT vs. SLIT to Modify Allergic Disease.

Objectives

Discuss the latest data on the efficacy and safety of SCIT compared to SLIT for grass pollen allergy
Upon completion of this activity, participants will be able to discuss the latest data on the efficacy and safety of SCIT compared to SLIT for grass pollen allergy.
Identify several newly discovered biomarkers for AIT efficacy
Upon completion of this activity, participants will be able to identify several newly discovered biomarkers for AIT efficacy.
Discuss and explain safety and adherence issues of SLIT and SCIT and utilize resources to try to overcome them
Upon completion of this activity, participants will be able to discuss and explain safety and adherence issues of SLIT and SCIT and utilize resources to try to overcome them.
Stephen R. Durham (MA MD FRCP), Mohamed H. Shamji (PhD FAAAAI), and Giovanni Passalacqua (MD)

Author Information Play Video Bio

Stephen R. Durham (MA MD FRCP), Mohamed H. Shamji (PhD FAAAAI), and Giovanni Passalacqua (MD)
on behalf of American Academy of Allergy Asthma & Immunology

The American Academy of Allergy, Asthma & Immunology (AAAAI) is a professional organization with nearly 7,000 members in the United States, Canada and 72 other countries. This membership includes allergist / immunologists, other medical specialists, allied health and related healthcare professionals—all with a special interest in the research and treatment of allergic and immunologic diseases.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.25 Credits
  • California Board of Registered Nursing (CBRN)
  • 1.25 Hours

Faculty and Disclosures

Stephen R. Durham, MA MD FRCP

Stephen R. Durham, MA MD FRCP

Potential Conflict

Consultant: Biomay via Imperial College
Advisory Board: Circassia via Imperial
College
Consultant: Anergis
Consultant: Boehringer Ingelheim
Speaker: EuroUPDATE
Merck (Ongoing): Consultancy via Imperial
College
Immune Tolerance Network (Ongoing):
Research salary support via Imperial
College
Mohamed H. Shamji, PhD FAAAAI

Mohamed H. Shamji, PhD FAAAAI

No Conflict
Giovanni Passalacqua, MD

Giovanni Passalacqua, MD

Potential Conflict

Speaker: stallergenes
Speaker: lofarma
Speaker: gsk
Speaker: msd
Speaker: novartis
Speaker: meda
Speaker: ASTRAZENECA
Speaker: MENARINI
Speaker: ALLERGOPHARMA

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error